yeelon yeoh, teck yew low, nadiah abu, pey yee lee.  (2021).  regulation of signal transduction pathways in colorectal cancer: implications for therapeutic resistance.  - peerj.  1-55. 

pey yee lee, yeelon yeoh, nursyazwani omar, yuh-fen pung, lay cheng lim, teck yew low.  (2021).  molecular tissue profiling by maldi imaging: recent progress and applications in cancer research.  - critical reviews in clinical laboratory sciences.  513-529. 

teck yew low, m. aiman mohtar, pey yee lee, nursyazwani omar, houjiang zhou, mingliang ye.  (2021).  widening the bottleneck of phosphoproteomics: evolving strategies for phosphopeptide enrichment.  - mass spectrometry reviews.  309-333. 

pey yee lee, neda saraygord-afshari, teck yew low.  (2020).  the evolution of two-dimensional gel electrophoresis- from proteomics to emerging alternative applications.  - journal of chromatography a.  1-9. 

lee pey yee, junaida osman, low teck yew, rahman jamal.  (2019).  plasma/serum proteomics: depletion strategies for reducing high-abundance proteins for biomarker discovery.  - bioanalysis.  1799-1812. 

junaida osman, shing cheng tan, pey yee lee, teck yew low and rahman jamal.  (2019).  sudden cardiac death (scd) - risk stratification and prediction with molecular biomarkers.  - journal of biomedical science.  1-12. 

mia yang ang, teck yew low, pey yee lee, wan fahmi wan mohamad nazarie, victor guryev, rahman jamal.  (2019).  proteogenomics: from next-generation sequencing (ngs) and mass spectrometry-based proteomics to precision medicine.  - clinica chimica acta.  38-46. 

pey yee lee, teck yew low, rahman jamal.  (2019).  probing the endogenous peptidomes of cancer for biomarkers: a new endeavor.  - advances in clinical chemistry.  67-89. 

pey yee lee, siok-fong chin, teck yew low, rahman jamal.  (2018).  probing the colorectal cancer proteome for biomarkers: current status and perspectives.  - journal of proteomics.  .